Cargando…
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy versus palliative systemic chemotherapy in stomach cancer patients with peritoneal dissemination, the study protocol of a multicentre randomised controlled trial (PERISCOPE II)
BACKGROUND: At present, palliative systemic chemotherapy is the standard treatment in the Netherlands for gastric cancer patients with peritoneal dissemination. In contrast to lymphatic and haematogenous dissemination, peritoneal dissemination may be regarded as locoregional spread of disease. Admin...
Autores principales: | Koemans, W. J., van der Kaaij, R. T., Boot, H., Buffart, T., Veenhof, A. A. F. A., Hartemink, K. J., Grootscholten, C., Snaebjornsson, P., Retel, V. P., van Tinteren, H., Vanhoutvin, S., van der Noort, V., Houwink, A., Hahn, C., Huitema, A. D. R., Lahaye, M., Los, M., van den Barselaar, P., Imhof, O., Aalbers, A., van Dam, G. M., van Etten, B., Wijnhoven, B. P. L., Luyer, M. D. P., Boerma, D., van Sandick, J. W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501330/ https://www.ncbi.nlm.nih.gov/pubmed/31060544 http://dx.doi.org/10.1186/s12885-019-5640-2 |
Ejemplares similares
-
Treatment of Peritoneal Dissemination in Stomach Cancer Patients With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Rationale and Design of the PERISCOPE Study
por: van der Kaaij, Rosa T, et al.
Publicado: (2017) -
Factors influencing long‐term survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei originating from appendiceal neoplasms
por: van Eden, W. J., et al.
Publicado: (2019) -
Venous thromboembolism during preoperative chemotherapy in the CRITICS gastric cancer trial
por: Slagter, Astrid E., et al.
Publicado: (2020) -
Effect of intraperitoneal chemotherapy concentration on morbidity and survival
por: Elekonawo, F. M. K., et al.
Publicado: (2020) -
CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer
por: Slagter, Astrid E., et al.
Publicado: (2018)